Status:
TERMINATED
Development of Resistance Mutations in Pregnant HIV-positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
Lead Sponsor:
Hadassah Medical Organization
Conditions:
HIV Infections
Eligibility:
FEMALE
18+ years
Brief Summary
It has been shown that treatment of HIV-positive women with antiretroviral medication during pregnancy reduces the risk of HIV transmission to the child. However, such treatment could lead to the sele...
Detailed Description
The project will be performed in collaboration with the Israeli National HIV Reference Center Laboratory, which maintains a national bank of HIV-positive blood samples, and with HIV/AIDS treatment cen...
Eligibility Criteria
Inclusion
- HIV-positive women currently pregnant or with a past pregnancy in Israel
- Blood/plasma samples available before and/or after perinatal antiretroviral treatment (before or during pregnancy if not treated)
- HIV viral load in the samples adequate for resistance testing (approximately 1000 copies/ml)
- Informed consent obtained
Exclusion
- Samples not available or inadequate viral load
- Informed consent not obtained
Key Trial Info
Start Date :
March 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00197366
Start Date
March 1 2005
End Date
December 1 2007
Last Update
November 28 2017
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Soroka University Medical Center
Beersheva, Israel, 84101
2
Rambam Medical Center
Haifa, Israel
3
AIDS Center, Hadassah-Hebrew U Medical Organisation
Jerusalem, Israel, 92100
4
Meir Hospital Sapir Medical Center
Kfar Saba, Israel, 95847